Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

21.99
Delayed Data
As of 3:59pm ET
 -1.40 / -5.99%
Today’s Change
12.56
Today|||52-Week Range
72.85
-64.08%
Year-to-Date
Endo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change
4:04pm / TheStreet.com - Paid Partner Content
Why Endo International plc Jumped Higher Today
Sep 23 / MotleyFool.com - Paid Partner Content
Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps
11:52am / Zacks.com - Paid Partner Content
Drugmaker Endo rises on leadership change
Sep 23 / FT.com - Paid Partner Content
Company News for September 26, 2016
10:51am / Zacks.com - Paid Partner Content
Endo (ENDP) Stock Soars After Campanelli Named CEO
Sep 23 / TheStreet.com - Paid Partner Content
Changes at the Top for Endo Could Benefit Its Smaller Partners
9:14am / TheStreet.com - Paid Partner Content
Wallace Weitz's Largest 2nd-Quarter Trades
Sep 22 / GuruFocus News - Paid Partner Content
Why Twitter, Endo International, and Hyster-Yale Materials Handling Jumped Today
Sep 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close23.39
Today’s open23.29
Day’s range21.77 - 23.44
Volume8,552,656
Average volume (3 months)7,722,258
Market cap$5.2B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-2.15%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.87

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.36-1.15%
UTHRUnited Therapeutics ...-1.64-1.29%
TSROTESARO Inc-0.77-0.71%
AGNPRAAllergan plc-13.37-1.56%
Data as of 4:02pm ET, 09/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.83
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs